Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis

Xavier Bossuyt, Jan Willem Cohen Tervaert, Yoshihiro Arimura, Daniel Blockmans, Luis Felipe Flores-Suárez, Loïc Guillevin, Bernhard Hellmich, David Jayne, J. Charles Jennette, Cees G.M. Kallenberg, Sergey Moiseev, Pavel Novikov, Antonella Radice, Judith Anne Savige, Renato Alberto Sinico, Ulrich Specks, Pieter van Paassen, Ming Hui Zhao, Niels Rasmussen, Jan DamoiseauxElena Csernok

Research output: Contribution to journalReview article

55 Citations (Scopus)

Abstract

Anti-neutrophil cytoplasmic antibodies (ANCAs) are valuable laboratory markers used for the diagnosis of well-defined types of small-vessel vasculitis, including granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). According to the 1999 international consensus on ANCA testing, indirect immunofluorescence (IIF) should be used to screen for ANCAs, and samples containing ANCAs should then be tested by immunoassays for proteinase 3 (PR3)-ANCAs and myeloperoxidase (MPO)-ANCAs. The distinction between PR3-ANCAs and MPO-ANCAs has important clinical and pathogenic implications. As dependable immunoassays for PR3-ANCAs and MPO-ANCAs have become broadly available, there is increasing international agreement that high-quality immunoassays are the preferred screening method for the diagnosis of ANCA-associated vasculitis. The present Consensus Statement proposes that high-quality immunoassays can be used as the primary screening method for patients suspected of having the ANCA-associated vaculitides GPA and MPA without the categorical need for IIF, and presents and discusses evidence to support this recommendation.

Original languageEnglish (US)
Pages (from-to)683-692
Number of pages10
JournalNature reviews. Rheumatology
Volume13
Issue number11
DOIs
StatePublished - Nov 1 2017

Fingerprint

Microscopic Polyangiitis
Antineutrophil Cytoplasmic Antibodies
Granulomatosis with Polyangiitis
Myeloblastin
Immunoassay
Peroxidase
Indirect Fluorescent Antibody Technique
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Vasculitis

ASJC Scopus subject areas

  • Rheumatology

Cite this

Bossuyt, X., Cohen Tervaert, J. W., Arimura, Y., Blockmans, D., Flores-Suárez, L. F., Guillevin, L., ... Csernok, E. (2017). Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nature reviews. Rheumatology, 13(11), 683-692. https://doi.org/10.1038/nrrheum.2017.140

Position paper : Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. / Bossuyt, Xavier; Cohen Tervaert, Jan Willem; Arimura, Yoshihiro; Blockmans, Daniel; Flores-Suárez, Luis Felipe; Guillevin, Loïc; Hellmich, Bernhard; Jayne, David; Jennette, J. Charles; Kallenberg, Cees G.M.; Moiseev, Sergey; Novikov, Pavel; Radice, Antonella; Savige, Judith Anne; Sinico, Renato Alberto; Specks, Ulrich; van Paassen, Pieter; Zhao, Ming Hui; Rasmussen, Niels; Damoiseaux, Jan; Csernok, Elena.

In: Nature reviews. Rheumatology, Vol. 13, No. 11, 01.11.2017, p. 683-692.

Research output: Contribution to journalReview article

Bossuyt, X, Cohen Tervaert, JW, Arimura, Y, Blockmans, D, Flores-Suárez, LF, Guillevin, L, Hellmich, B, Jayne, D, Jennette, JC, Kallenberg, CGM, Moiseev, S, Novikov, P, Radice, A, Savige, JA, Sinico, RA, Specks, U, van Paassen, P, Zhao, MH, Rasmussen, N, Damoiseaux, J & Csernok, E 2017, 'Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis', Nature reviews. Rheumatology, vol. 13, no. 11, pp. 683-692. https://doi.org/10.1038/nrrheum.2017.140
Bossuyt, Xavier ; Cohen Tervaert, Jan Willem ; Arimura, Yoshihiro ; Blockmans, Daniel ; Flores-Suárez, Luis Felipe ; Guillevin, Loïc ; Hellmich, Bernhard ; Jayne, David ; Jennette, J. Charles ; Kallenberg, Cees G.M. ; Moiseev, Sergey ; Novikov, Pavel ; Radice, Antonella ; Savige, Judith Anne ; Sinico, Renato Alberto ; Specks, Ulrich ; van Paassen, Pieter ; Zhao, Ming Hui ; Rasmussen, Niels ; Damoiseaux, Jan ; Csernok, Elena. / Position paper : Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. In: Nature reviews. Rheumatology. 2017 ; Vol. 13, No. 11. pp. 683-692.
@article{39276bfe0e5c47cfa5e675259675a724,
title = "Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis",
abstract = "Anti-neutrophil cytoplasmic antibodies (ANCAs) are valuable laboratory markers used for the diagnosis of well-defined types of small-vessel vasculitis, including granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). According to the 1999 international consensus on ANCA testing, indirect immunofluorescence (IIF) should be used to screen for ANCAs, and samples containing ANCAs should then be tested by immunoassays for proteinase 3 (PR3)-ANCAs and myeloperoxidase (MPO)-ANCAs. The distinction between PR3-ANCAs and MPO-ANCAs has important clinical and pathogenic implications. As dependable immunoassays for PR3-ANCAs and MPO-ANCAs have become broadly available, there is increasing international agreement that high-quality immunoassays are the preferred screening method for the diagnosis of ANCA-associated vasculitis. The present Consensus Statement proposes that high-quality immunoassays can be used as the primary screening method for patients suspected of having the ANCA-associated vaculitides GPA and MPA without the categorical need for IIF, and presents and discusses evidence to support this recommendation.",
author = "Xavier Bossuyt and {Cohen Tervaert}, {Jan Willem} and Yoshihiro Arimura and Daniel Blockmans and Flores-Su{\'a}rez, {Luis Felipe} and Lo{\"i}c Guillevin and Bernhard Hellmich and David Jayne and Jennette, {J. Charles} and Kallenberg, {Cees G.M.} and Sergey Moiseev and Pavel Novikov and Antonella Radice and Savige, {Judith Anne} and Sinico, {Renato Alberto} and Ulrich Specks and {van Paassen}, Pieter and Zhao, {Ming Hui} and Niels Rasmussen and Jan Damoiseaux and Elena Csernok",
year = "2017",
month = "11",
day = "1",
doi = "10.1038/nrrheum.2017.140",
language = "English (US)",
volume = "13",
pages = "683--692",
journal = "Nature Reviews Rheumatology",
issn = "1759-4790",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Position paper

T2 - Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis

AU - Bossuyt, Xavier

AU - Cohen Tervaert, Jan Willem

AU - Arimura, Yoshihiro

AU - Blockmans, Daniel

AU - Flores-Suárez, Luis Felipe

AU - Guillevin, Loïc

AU - Hellmich, Bernhard

AU - Jayne, David

AU - Jennette, J. Charles

AU - Kallenberg, Cees G.M.

AU - Moiseev, Sergey

AU - Novikov, Pavel

AU - Radice, Antonella

AU - Savige, Judith Anne

AU - Sinico, Renato Alberto

AU - Specks, Ulrich

AU - van Paassen, Pieter

AU - Zhao, Ming Hui

AU - Rasmussen, Niels

AU - Damoiseaux, Jan

AU - Csernok, Elena

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Anti-neutrophil cytoplasmic antibodies (ANCAs) are valuable laboratory markers used for the diagnosis of well-defined types of small-vessel vasculitis, including granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). According to the 1999 international consensus on ANCA testing, indirect immunofluorescence (IIF) should be used to screen for ANCAs, and samples containing ANCAs should then be tested by immunoassays for proteinase 3 (PR3)-ANCAs and myeloperoxidase (MPO)-ANCAs. The distinction between PR3-ANCAs and MPO-ANCAs has important clinical and pathogenic implications. As dependable immunoassays for PR3-ANCAs and MPO-ANCAs have become broadly available, there is increasing international agreement that high-quality immunoassays are the preferred screening method for the diagnosis of ANCA-associated vasculitis. The present Consensus Statement proposes that high-quality immunoassays can be used as the primary screening method for patients suspected of having the ANCA-associated vaculitides GPA and MPA without the categorical need for IIF, and presents and discusses evidence to support this recommendation.

AB - Anti-neutrophil cytoplasmic antibodies (ANCAs) are valuable laboratory markers used for the diagnosis of well-defined types of small-vessel vasculitis, including granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). According to the 1999 international consensus on ANCA testing, indirect immunofluorescence (IIF) should be used to screen for ANCAs, and samples containing ANCAs should then be tested by immunoassays for proteinase 3 (PR3)-ANCAs and myeloperoxidase (MPO)-ANCAs. The distinction between PR3-ANCAs and MPO-ANCAs has important clinical and pathogenic implications. As dependable immunoassays for PR3-ANCAs and MPO-ANCAs have become broadly available, there is increasing international agreement that high-quality immunoassays are the preferred screening method for the diagnosis of ANCA-associated vasculitis. The present Consensus Statement proposes that high-quality immunoassays can be used as the primary screening method for patients suspected of having the ANCA-associated vaculitides GPA and MPA without the categorical need for IIF, and presents and discusses evidence to support this recommendation.

UR - http://www.scopus.com/inward/record.url?scp=85032643949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032643949&partnerID=8YFLogxK

U2 - 10.1038/nrrheum.2017.140

DO - 10.1038/nrrheum.2017.140

M3 - Review article

C2 - 28905856

AN - SCOPUS:85032643949

VL - 13

SP - 683

EP - 692

JO - Nature Reviews Rheumatology

JF - Nature Reviews Rheumatology

SN - 1759-4790

IS - 11

ER -